Clinical Trials Directory

Trials / Unknown

UnknownNCT00966082

EBL Versus EBL and Propranolol for the Prevention of Variceal Rebleeding in Pts With Previous Variceal Treatment

RCT Comparing the Efficacies of Endoscopic Band Ligation (EBL) and Combined Treatment of Beta-blocker and EBL for the Prevention of Esophageal Variceal Rebleeding in Patients With Previous Endoscopic Variceal Treatment

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Korea University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients who were previously performed endoscopic variceal treatment.

Detailed description

Both propranolol and endoscopic band ligation (EBL) are effective for prevention of variceal rebleeding. Recently several studies compared the efficacy of EBL alone and with a combination of propranolol and EBL. However, the results of recent studies showed discrepancy. In addition, most of all recent studies included patients without previous endoscopic treatment for varices. This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients who were previously performed endoscopic variceal treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREendoscopic band ligationPerform EBL until esophageal varices are eradicated, and then follow-up endoscopy with 3-6 months interval
PROCEDUREendoscopic band ligation+PropranololPerform EBL same as EBL group. In addition, take propranolol to reduce 25% in HR or HR ≤55/min

Timeline

Start date
2008-08-01
Primary completion
2019-07-01
Completion
2021-07-01
First posted
2009-08-26
Last updated
2017-08-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00966082. Inclusion in this directory is not an endorsement.